期刊文献+

多囊卵巢综合征患者控制性超促排卵过程AMH和INHB浓度变化的临床研究 被引量:21

Changes of anti-Mullerian hormone( AMH ) and inhibin B( INHB ) during controlled ovarian hyperstimulation in polycystic ovarian syndrome
下载PDF
导出
摘要 目的探讨多囊卵巢综合征(polycystic ovarian syndrome,PCOS)患者控制性超促排卵(controlled ovarian hyperstimulation,COH)过程中血清抗苗勒管激素(anti-Müllerian hormone,AMH)和抑制素B(inhibin B,INHB)浓度的变化及其对COH结局的预测价值。方法 PCOS组患者37例,对照组患者41例。检测患者月经周期第2/3天(D2/3)、促性腺激素(gonadotrophin,Gn)刺激第5天(D5)、人绒毛膜促性腺激素(human chorionic gonadotropin,hCG)日(D-hCG)血清AMH及INHB浓度及取卵日卵泡液中AMH及INHB浓度,观察其动态变化及其对COH结局的影响。结果在COH过程中,血清AMH浓度逐渐降低,而血清INHB浓度逐渐升高。PCOS组患者hCG日血清雌二醇(estrodiol,E2)浓度、获卵数、冷冻胚胎数较对照组明显升高(P<0.05,P<0.001),而Gn用量、受精率均低于对照组,差异有统计学意义(P<0.05),2组患者的临床妊娠率比较,差异无统计学意义(P>0.05)。血清AMH和INHB浓度与Gn剂量、hCG日E2浓度具有相关性(P<0.05,P<0.001),但是与获卵数、临床妊娠率无相关性(P>0.05)。结论 PCOS患者AMH和INHB浓度在COH过程中呈现动态变化,可以预测COH中卵巢的反应性,但是对超促排卵结局的预测价值还有待进一步研究。 Objective To explore dynamics of anti-Mullerian hormone ( AMH ) and inhibin B ( INHB ) during controlled ovarian hyperstimulation ( COH) in polycystic ovarian syndrome ( PCOS ) , and assess the value of these dynamic changes on the prediction of outcome in PCOS patients undergoing in vitro fertilization ( IVF) .Methods Thirty-seven women with PCOS and 41 women with normal ovarian reserve as the control were recruited in the study .AMH and INHB levels were measured in serum on menstrual cycle day 2 or 3 (D2/3), day 5 of gonadotropin stimulation(D5), human chorionic gonadotropin(hCG) day (D-hCG) and follicular fluid(FF) on oocyte retrieval day during IVF treatment , and the relationship of AMH and INHB levels with COH outcomes was analyzed .Rseults (1) AMH levels gradually decreased while INHB levels gradually increased from D 2/3to D-hCG during COH procedure .(2) Significant differences were observed in estradiol(E2) levels of hCG day, gonadotrophin(Gn) dosage, retrieved oocytes, fertilization rate and frozen embryos (P〈0.05) in PCOS and control groups.(3) There was a negative correlation in serum AMH and INHB levels on D 2/3, D5 and D-hCG with Gn dosage, positive correlation with estradiol of hCG day (P〈0.05, P〈0.001), no correlation with oocytes retrieval and clinical pregnancy rate(P〉0.05).Conclusion Serum AMH and INHB levels are demonstrated to have dynamic changes during COH procedure in PCOS patients , and reflect the ovarian response in COH .The predictive value of AMH and INHB on COH outcomes in PCOS remains to be evaluated via further research .
出处 《首都医科大学学报》 CAS 2014年第4期402-406,共5页 Journal of Capital Medical University
基金 国家自然科学基金项目(81170542) 北京市卫生系统高层次技术人才培养项目(2011-3-071) 首都医科大学附属北京妇产医院 北京妇幼保健院学科带头人项目(2013-2)~~
关键词 多囊卵巢综合征 控制性超促排卵 抗苗勒管激素 抑制素B polycystic ovarian syndrome (PCOS) controlled ovarian hyperstimulation (COH) anti-Mullerian hormone (AMH) inhibin B(INHB)
  • 相关文献

参考文献14

  • 1Hossain M M,Cao M,Wang Q,et al.Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model[J].J Ovarian Res,2013,6(1):36.
  • 2Pigny P,Merlen E,Robert Y,et al.Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome:relationship to the ovarian follicle excess and to the follicular arrest[J].J Clin Endocrinol Metab,2003,88(12):5957 5962.
  • 3陈薪,尹敏娜,叶德盛,何于夏,陈士岭.血清与卵泡液抗苗勒氏管激素对多囊卵巢综合症患者体外受精-胚胎移植临床结果的预测价值[J].南方医科大学学报,2013,33(4):546-549. 被引量:37
  • 4Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J].Hum Reprod,2004,19(1):41 47.
  • 5Legro R S,Barnhart H X,Schlaff W D,et al.Clomiphene,metformin,or both for infertility in the polycystic ovary syndrome[J].N Engl J Med,2007,356(6):551-566.
  • 6Visser J A,de Jong F H,Laven J S,et al.Anti-Mullerian hormone:a new marker for ovarian function[J].Reproduction,2006,131(1):1 9.
  • 7La Marca A,Stabile G,Artenisio A C,et al.Serum antiMullerian hormone throughout the human menstrual cycle[J].Hum Reprod,2006,21(12):3103 3107.
  • 8Cook C L, Siow Y, Taylor S, et al. Serum mullerian-inhib- iting substance levels during normal menstrual cycles [ J ]. Fertil Steril, 2000,73 (4) :859-861.
  • 9Lee J R,Kim S H,Kim S M,et al.Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction[J].Hum Reprod,2010,25(10):2597 2604.
  • 10杨瑞,玛依努尔·尼牙教,朱开春,滕雪峰.多囊卵巢综合征患者降调后抗苗勒管激素水平对妊娠结局的预测价值[J].医学临床研究,2012,29(2):229-232. 被引量:6

二级参考文献49

  • 1Laven JS, Imani B, Eijkemans MJ, et al.Absent biologically relevant association between serum inhibin B concentration and characteristics of ploycystic ovary syndrome in nomogonadotrophic anovulatory infertility[J].Hum Reprod,2001,16(7):1359-1364.
  • 2Welt CK,Taylor AE,Fox J,et al.Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B Biosynthesis[J].J Clin Endocrinol Metab,2005,90(10):5582-5587.
  • 3Cortet-Rudelli C,Pigny P,Decanter C,et al.Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary, syndr9rne[J]. Fertil Steril, 2002, , 77(2), 281.
  • 4Weenen C,Laven JS,von Bergh AR,et al.Anti-Mullerian hormone expression pattern in the human ovary:potential implications for initial and cyclic follicle recruitment[J].Mol Hum Reprod,2004,10(2):77-83.
  • 5Pigny P,Jonard S,Robert Y,et al.Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome[J].Clin Endocrinol Metab,2006,91(3):941-945.
  • 6中华医学会.临床诊疗指南辅助生殖技术与精子库分册[M].北京:人民卫生出版社,2009:20-27.
  • 7中华人民共和国卫生部.中华人民共和国卫生行业标准[M].北京:人民卫生出版社,2011:330.
  • 8Arabzadeh S,Hossein G,Rashidi BH,et al.Comparing serum basal and follicular fluid levels of anti-Müllerian ormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome[J].Ann Saudi Med,2010,30(6):442-447.
  • 9Dehghani-Firouzabadi R,Tayebi N,Asgharnia M.Serum level of Anti-Mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles[J].Arch Iran Med,2008,11 (4):371-376.
  • 10Wu CH,Chen YC,Hung H,et al.Serum Anti-Mullerian hormone predicts ovarian response and cycle outcome in IVF patients[J].Assist Reprod Genet,2009,26(7):383-389.

共引文献87

同被引文献196

  • 1卓义丹.口服避孕药预处理应用于辅助生育技术中多囊卵巢综合征患者的研究[J].医学信息(医学与计算机应用),2014,0(31):27-27. 被引量:3
  • 2陈子江.高度重视多囊卵巢综合征的规范化诊断与治疗[J].中华妇产科杂志,2007,42(5):289-290. 被引量:69
  • 3金敏,蔡婕,胡燕军,陆秀娥,黄荷凤.cathpsin D在多囊卵巢综合征卵巢组织中的表达[J].浙江大学学报(医学版),2007,36(5):429-432. 被引量:2
  • 4谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 5Franks S.Polycystic ovary syndrome[J].N Engl J Med,1995,333:853-861.
  • 6Franks S,Stark J,Hardy K.Follicle dynamics and anovulation in polycystic ovary syndrome[J].Hum Reprod Update,2008,14:367-378.
  • 7Nielsen ME,Rasmussen IA,Kristensen SG,et,al.In human granulosa cells from small antral follicles,androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA[J].Mol Hum Reprod,2011,17:63-70.
  • 8Kninger A,Sauter L,Edimiris P,et al.Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome[J].Hum Reprod,2014,29:518-524.
  • 9Mashiach R,Amit A,Hasson J,et,al.Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation,fertilization rate,and embryonic development in patients with polycystic ovary syndrome[J].Fertil Steril,2010,93:2299-2302.
  • 10Hendrix AO,Hughes CL,Selgrade JF.Modeling Endocrine Control of the Pituitary-Ovarian Axis:Androgenic Influence and Chaotic Dynamics[J].Bull Math Biol,2014,76:136-156.

引证文献21

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部